Abate AS Industries Limited has disclosed a change in shareholding by its promoter group entity under SEBI regulations. Al Salama Eye Research Foundation, classified as a promoter group member, has increased its stake in the company through open market transactions on BSE.

Transaction Details

The foundation executed a purchase transaction of equity shares over a three-day period in February 2026. The acquisition demonstrates continued confidence from the promoter group in the company's prospects.

Shareholding Changes

The transaction resulted in a marginal increase in the foundation's ownership percentage in Abate AS Industries. The foundation's shareholding position before and after the transaction shows steady accumulation of equity.

Timeline and Compliance

The share acquisition occurred between February 24-26, 2026, with the company receiving intimation on February 27, 2026. The disclosure was made in compliance with Regulation 7(2) of SEBI Prohibition of Insider Trading Regulations, 2015.

The foundation, based in Perinthalama nna, Kerala, holds PAN number AABTA4125D. Company Secretary Heena Kausar Rangari submitted the regulatory filing to BSE Limited on March 2, 2026, ensuring adherence to disclosure requirements for promoter group transactions.

Abate AS Industries Limited has announced the successful launch of its indigenously developed Electronic Medical Record (EMR) System, designed as a comprehensive Eye Hospital Clinic Management System. The announcement was made through a regulatory filing under Regulation 30 of SEBI (LODR) Regulations, 2015, dated February 17, 2026.

System Launch and Implementation

The system was launched through the company's healthcare subsidiary M/s Prudential Management Services Private Limited at Abate EYE Hospital. The comprehensive digital ecosystem is tailored specifically for ophthalmic practice and represents more than standard EMR functionality.

Development and Objectives

Developed through the collective efforts of the company's internal medical, clinical, operational, and technical teams, this digital transformation initiative aims to achieve multiple strategic objectives:

• Enhance data accuracy and clinical documentation standards
• Improve inter-departmental coordination and workflow efficiency
• Enable real-time reporting and centralized management oversight
• Strengthen patient experience through faster and more structured service delivery
• Support scalability across current and future branches

Patient Management Features

The newly implemented system includes an integrated online appointment management module that enables patients to directly select available consultation slots and complete digital payments in advance. The company anticipates that this structured scheduling framework will significantly reduce patient no-show ratios and optimize doctor chair-time utilisation.

Operational Efficiency Benefits

The automation of appointment handling and billing workflows is expected to reduce manual administrative dependency at call center and reception levels. This improvement is anticipated to enhance cost efficiency and contribute positively to operating margins over time, while improving operational planning efficiency.

Strategic Significance

The implementation of this advanced Eye Hospital Clinic Management System marks a significant milestone in the company's digital healthcare journey. The launch reinforces the company's commitment to innovation, operational excellence, and patient-centric care in alignment with its core philosophy of "Advance and Ethical." The system represents a comprehensive approach to digital healthcare management specifically designed for ophthalmic practice requirements.